Skip to content

Aronia, Cognition, and Eye Health (ACE)

Aronia, Cognition, and Eye Health

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05683002
Acronym
ACE
Enrollment
44
Registered
2023-01-12
Start date
2022-12-08
Completion date
2026-01-01
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Function

Keywords

Supplementation, Cognition, Cognitive Function

Brief summary

There is great interest in improving cognitive performance and eye health as working from home becomes more prominent. Working from home as well as stress in the workplace is an increasing problem. Students and work professional can therefore benefit from improved attention and thus performance in academic and other work environments. A completely natural supplement with aronia melanocarpa extract could be a promising way to naturally improve cognitive performance

Detailed description

The shift of on-site education/working to online education/working has had a detrimental impact on motivation to study or work and ultimately on mental health. Moreover, online education has been shown to have a negative effect on concentration, learning, and academic performance. Stress in the workplace is an increasing problem, leading to decreased productivity and overall well-being of working adults. Consequently, there is a great interest in improving cognitive performance, including memory and attention. Previous studies in young adults have mainly focused on acute or short-term (e.g. 1 week) effects of anthocyanin supplementation on cognitive performance. The research hypothesis of the current study is that long term (6 weeks) AME supplementation affects domains of cognitive performance in a randomized, double-blind, placebo controlled, cross-over study in healthy young adults (18-35 years old).

Interventions

DIETARY_SUPPLEMENTAronia supplementation

As described in experimental arm

DIETARY_SUPPLEMENTCellulose supplementation

As described in placebo comparator arm

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER
BioActor B.V.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Block Randomization

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women, aged between 18-35 years * BMI between 18-30 kg/m2 * Systolic blood pressure \< 160 mmHg and diastolic blood pressure \< 100 mmHg * Stable body weight (weight gain or loss \< 3 kg in the past three months) * Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study * No difficult venipuncture as evidenced during the screening visit

Exclusion criteria

* Smoking or smoking cessation \< 12 months * Contact lens wearers * Past refractive surgery * Severe medical conditions, including asthma, chronic obstructive pulmonary disease (COPD), kidney failure, auto-inflammatory diseases, rheumatoid arthritis, diabetes mellitus, cardiovascular disease * Use of dietary supplements or medication affecting the main outcomes of the study * Use of an investigational product within another biomedical intervention trial within the previous month * Familial hypercholesterolemia * Abuse of drugs * More than 3 alcoholic consumptions per day

Design outcomes

Primary

MeasureTime frameDescription
Cognitive FunctionAfter 6 weeks of supplementationQuantified through the Cambridge Neuropsychological Test Automated Battery (CANTAB). Focus on attention/psychomotor speed, memory, and executive function

Secondary

MeasureTime frameDescription
Eye HealthAt baseline and after 6 weeks of supplementationTear fluid collection (volume)
Subjective Eye FatigueAt baseline and after 6 weeks of supplementationSubjective Eye Fatigue Questionnaire
Vascular FunctionAt baseline and after 6 weeks of supplementationFundus photography

Countries

Netherlands

Contacts

PRINCIPAL_INVESTIGATORJogchum Plat, Prof

Maastricht University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026